Telemedicine-Delivered Buprenorphine Treatment in the Age of COVID-19 ADP

Telemedicine-Delivered Buprenorphine Treatment in the Age of COVID-19 ADP

There are not enough treatment providers to meet the needs of our patients with OUD. Telemedicine can increase access to patients who require ongoing substance use disorder treatment. However, there are numerous regulatory, logistical, and other clinical questions, which are also rapidly changing, around implementing telemedicine delivery of medication treatment for OUD (tele-MOUD). In this presentation, we will: present evidence on tele-MOUD but focus most of the discussion on clinical considerations in using implementing telemedicine to deliver quality buprenorphine treatment.

  • Provider:American Academy of Addiction Psychiatry
  • Activity Link: https://education.sudtraining.org/URL/Telemedicine-DeliveredBuprenorphineTreatmentintheAgeofCOVID-19ONDEMAND
  • Start Date: 2024-04-10 05:00:00
  • End Date: 2024-04-10 05:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
    Social Work: 1.0 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.